Skip to content

RLAY

Relay Therapeutics, Inc.

Stock

$18.96+0.47 (+2.54%)Close Oct 2, 2026

Free cash flow, 2025
−$236M

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025−$236M—
2024−$251M—
2023−$304M—
2022−$239M—
2021−$78M—
2020−$104M—
2019−$74M—